Viewing Study NCT07088068


Ignite Creation Date: 2025-12-24 @ 5:43 PM
Ignite Modification Date: 2025-12-27 @ 12:22 PM
Study NCT ID: NCT07088068
Status: RECRUITING
Last Update Posted: 2025-12-03
First Post: 2025-07-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Sponsor: Sanofi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module